share_log

2022年深圳微芯生物科技股份有限公司向不特定对象发行可转换公司债券2024年跟踪评级报告

In 2022, Shenzhen Chipscreen Biosciences Co., Ltd. issued convertible corporate bonds to unspecified investors. The tracking rating report is for 2024.

Sensex a share ·  Jun 18
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more